Pfizer Competitive Advantage

2127 Words5 Pages

Pfizer has a senior leadership that is strongly committed to using analytics to reduce operating costs while increasing revenues. One of the ways senior leadership has accomplished this was to focus on real-time data collection as a strategy in customer analytics. Sales personnel are now equipped with tablets that allows Pfizer analytics teams to collect large amounts of data from customers in real-time. The data is synced daily thus giving Pfizer the ability to detect patterns which allows them to make decisions concerning sales more efficiently (Davenport& Harris 2011).
The above example shows that Pfizer is building on the foundation of analytics to predict the needs of the customer (which is the physicians in the case above). It …show more content…

This allowed Pfizer to make decisions based on patterns and trends before other companies. The ability to use real-time data to drive the decision process based on market trends could be considered a competitive advantage for Pfizer.
The decision process is based on segmenting the customers into groups. Each group presents a different need that Pfizer then tailors and presents the recommended products to meet those specific needs. The process is streamlined to only present the customer with what he or she needs, cutting costs (Davenport& Harris 2011).
Pfizer creates competitive advantage by reaching out to prospective partners that are willing to collaborate on innovative solutions. Prospective partners are those that provide cutting edge technology in analytics-enabled services, healthcare decision-support tools, open innovation platforms and other open platforms (ET CIO 2014). Each of these areas provide a way for Pfizer to collect, store and analyze large amounts of data. Companies such as IBM collaborate with Pfizer to create new ways of collecting patient data (Miller 2016). Creating Cloud services, Pfizer taps into a way to store clinical trial data from many different trials and researchers. This data is used to cut down on the amount of time used to execute clinical trials (Preston

Open Document